Details of the Drug Therapeutic Target (DTT)
General Information of Drug Therapeutic Target (DTT) (ID: TTNJS0A)
| DTT Name | HUMAN excitatory amino acid transporter 1 (EAAT1) | ||||
|---|---|---|---|---|---|
| Synonyms | Solute carrier family 1 member 3; Sodium-dependent glutamate/aspartate transporter 1; GLAST-1 | ||||
| Gene Name | SLC1A3 | ||||
| BioChemical Class |
SLC1A3 subfamily
|
||||
| UniProt ID | |||||
| TTD ID | |||||
| 3D Structure | |||||
| Sequence |
MTKSNGEEPKMGGRMERFQQGVRKRTLLAKKKVQNITKEDVKSYLFRNAFVLLTVTAVIV
GTILGFTLRPYRMSYREVKYFSFPGELLMRMLQMLVLPLIISSLVTGMAALDSKASGKMG MRAVVYYMTTTIIAVVIGIIIVIIIHPGKGTKENMHREGKIVRVTAADAFLDLIRNMFPP NLVEACFKQFKTNYEKRSFKVPIQANETLVGAVINNVSEAMETLTRITEELVPVPGSVNG VNALGLVVFSMCFGFVIGNMKEQGQALREFFDSLNEAIMRLVAVIMWYAPVGILFLIAGK IVEMEDMGVIGGQLAMYTVTVIVGLLIHAVIVLPLLYFLVTRKNPWVFIGGLLQALITAL GTSSSSATLPITFKCLEENNGVDKRVTRFVLPVGATINMDGTALYEALAAIFIAQVNNFE LNFGQIITISITATAASIGAAGIPQAGLVTMVIVLTSVGLPTDDITLIIAVDWFLDRLRT TTNVLGDSLGAGIVEHLSRHELKNRDVEMGNSVIEENEMKKPYQLIAQDNETEKPIDSET KM |
||||
| Function | Human protein solute carrier family 1 member 3 interacts with SARS-CoV-2 M protein with high significance, which indicates SLC1A3 as a potential therapeutic target. | ||||
| KEGG Pathway | |||||
| Reactome Pathway | |||||
The Drug Transporter (DTP) Role of This DTT
| DTT DTP Name | Excitatory amino acid transporter 1 (SLC1A3) | |||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gene Name | SLC1A3 | |||||||||||||||||||||||||||
|
1 Approved Drug(s) Transported by This DTT
|
||||||||||||||||||||||||||||
